These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2313850)

  • 41. Assisted Reproductive Technology Surveillance — United States, 2012.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
    MMWR Surveill Summ; 2015 Aug; 64(6):1-29. PubMed ID: 26270152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suspected adverse reactions, 2007.
    Dyer F; Spagnuolo-Weaver M; Coolees S; Tait A
    Vet Rec; 2008 Jul; 163(3):69-72. PubMed ID: 18702197
    [No Abstract]   [Full Text] [Related]  

  • 43. Reporting of adverse drug reactions by poison control centres in the US.
    Chyka PA; McCommon SW
    Drug Saf; 2000 Jul; 23(1):87-93. PubMed ID: 10915034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicians' liability for adverse drug reactions.
    Kaufman MB; Stoukides CA; Campbell NA
    South Med J; 1994 Aug; 87(8):780-4. PubMed ID: 8052883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis.
    Psaty BM; Furberg CD; Ray WA; Weiss NS
    JAMA; 2004 Dec; 292(21):2622-31. PubMed ID: 15572720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving the Food and Drug Administration's mandate to ensure postmarketing drug safety.
    Qato DM; Alexander GC
    JAMA; 2011 Oct; 306(14):1595-6. PubMed ID: 21990303
    [No Abstract]   [Full Text] [Related]  

  • 47. Capital punishment and the physician: the views of six Rhode Island physicians.
    Crowley JP; Ingall MA; Kahr FM; Braden W; Hershkowitz M; Rakatansky H
    R I Med; 1995 Aug; 78(8):215-21. PubMed ID: 7549022
    [No Abstract]   [Full Text] [Related]  

  • 48. How many deaths occur annually from adverse drug reactions in the United States?
    Chyka PA
    Am J Med; 2000 Aug; 109(2):122-30. PubMed ID: 10967153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of new adverse drug reactions. A review of the Food and Drug Administration's spontaneous reporting system.
    Rossi AC; Knapp DE
    JAMA; 1984 Aug 24-31; 252(8):1030-3. PubMed ID: 6748207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying adverse reactions to drugs. Reporting systems.
    Stern RS
    Clin Dermatol; 1986; 4(1):15-22. PubMed ID: 2978679
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of public education and continuing medical education on physician attitudes and behavior concerning cholesterol.
    Block L; Banspach SW; Gans K; Harris C; Lasater TM; Lefebvre RC; Carleton RA
    Am J Prev Med; 1988; 4(5):255-60. PubMed ID: 3224002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants.
    Mosholder AD; Pamer CA
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):33-6. PubMed ID: 16553527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reporting rates for severe hypersensitivity reactions associated with prescription-only drugs in outpatient treatment in Germany.
    Sachs B; Fischer-Barth W; Merk HF
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1076-84. PubMed ID: 26285651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assisted Reproductive Technology Surveillance - 
United States, 2013.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
    MMWR Surveill Summ; 2015 Dec; 64(11):1-25. PubMed ID: 26633040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-marketing surveillance of drugs. The spontaneous reporting scheme: role of the Adverse Drug Reactions Advisory Committee.
    Roeser HP; Rohan AP
    Med J Aust; 1990 Dec 3-17; 153(11-12):720-6. PubMed ID: 2099761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pilot projects to stimulate adverse drug reaction reporting.
    Fincham JE
    J Clin Pharm Ther; 1987 Aug; 12(4):243-7. PubMed ID: 3624325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physician Beliefs About Online Reporting of Quality and Experience Data.
    Lagu T; Haskell J; Cooper E; Harris DA; Murray A; Gardner RL
    J Gen Intern Med; 2019 Nov; 34(11):2542-2548. PubMed ID: 31463685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.